1. Home
  2. BBIO vs NFG Comparison

BBIO vs NFG Comparison

Compare BBIO & NFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • NFG
  • Stock Information
  • Founded
  • BBIO 2015
  • NFG 1902
  • Country
  • BBIO United States
  • NFG United States
  • Employees
  • BBIO N/A
  • NFG N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • NFG Oil/Gas Transmission
  • Sector
  • BBIO Health Care
  • NFG Utilities
  • Exchange
  • BBIO Nasdaq
  • NFG Nasdaq
  • Market Cap
  • BBIO 5.6B
  • NFG 6.2B
  • IPO Year
  • BBIO 2019
  • NFG N/A
  • Fundamental
  • Price
  • BBIO $36.08
  • NFG $69.75
  • Analyst Decision
  • BBIO Strong Buy
  • NFG Buy
  • Analyst Count
  • BBIO 13
  • NFG 2
  • Target Price
  • BBIO $48.33
  • NFG $72.50
  • AVG Volume (30 Days)
  • BBIO 2.5M
  • NFG 563.8K
  • Earning Date
  • BBIO 02-20-2025
  • NFG 01-29-2025
  • Dividend Yield
  • BBIO N/A
  • NFG 2.93%
  • EPS Growth
  • BBIO N/A
  • NFG N/A
  • EPS
  • BBIO N/A
  • NFG 0.84
  • Revenue
  • BBIO $217,765,000.00
  • NFG $1,944,810,000.00
  • Revenue This Year
  • BBIO $2,309.33
  • NFG $26.28
  • Revenue Next Year
  • BBIO N/A
  • NFG $9.85
  • P/E Ratio
  • BBIO N/A
  • NFG $83.03
  • Revenue Growth
  • BBIO 2209.77
  • NFG N/A
  • 52 Week Low
  • BBIO $21.62
  • NFG $45.32
  • 52 Week High
  • BBIO $41.04
  • NFG $69.71
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 73.73
  • NFG 81.76
  • Support Level
  • BBIO $33.73
  • NFG $60.48
  • Resistance Level
  • BBIO $36.24
  • NFG $61.62
  • Average True Range (ATR)
  • BBIO 1.63
  • NFG 1.07
  • MACD
  • BBIO 0.65
  • NFG 0.93
  • Stochastic Oscillator
  • BBIO 97.63
  • NFG 99.27

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About NFG National Fuel Gas Company

National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.

Share on Social Networks: